���
�a(ch��n)Ʒ
��(y��u)�|(zh��)�a(ch��n)Ʒ
�YӍ
�S��
���}
չ��
�˲�
Ʒ��
�Y��
���g(sh��)�īI(xi��n)
�IJ�
���
��Ʒ
���N
�D(zhu��n)������Ӌ�a(ch��n)Ʒ���S��
XIK-LZF���ٹܸ�������Ӌ XIE-LZF ����
���������ϵ�н��ٹܸ�������Ӌ���䃞(y��u)�����ܺͿɿ������Լ��^�õ����܃r��ȣ���ʯ������F�������ұ�����p����ʳƷ����ˎ��ˮ̎�����ИI(y��)�õ��ˏV���đ�(y��ng)��
���r�g:
2025-07-31
ԓ��˾�a(ch��n)Ʒ���
���ϣ�ƃx������˾
��2651�l
��54�
<<
22
23
24
25
26
27
28
29
30
31
>>
���®a(ch��n)Ʒ
UniPR1331
2025/8/5 13:26:40
PAWI-2
2025/8/5 13:26:38
(E/Z)-Raphin1
2025/8/5 13:26:33
HDAC6 degrader-4
2025/8/5 13:26:31
4-Hydroxyalternariol
2025/8/5 13:26:28
Phytomonic acid
2025/8/5 13:26:26
L-Cysteic acid (Standard)
2025/8/5 13:26:24
m-PEG3-aldehyde (stabilized with BHT)
2025/8/5 13:26:23
Methyl 2-hydroxyhexadecanoate
2025/8/5 13:26:21
���a(ch��n)�������͏Sȫ���O(sh��)��,������ե���O(sh��)��,־Ǭʳ���;����O(sh��)�乤�S
2025/8/5 13:26:21
4,5-DiHDPA lactone
2025/8/5 13:26:19
3-Hydroxyphenazepam
2025/8/5 13:26:18
Streptochlorin
2025/8/5 13:26:16
Diminazene aceturate (Standard)
2025/8/5 13:26:14
TMP-153
2025/8/5 13:26:10
HL001
2025/8/5 13:26:08
Dodecyl gallate (Standard)
2025/8/5 13:26:06
Prostaglandin F1�� alcohol
2025/8/5 13:26:03
Methyl 2-hydroxytricosanoate
2025/8/5 13:25:58
Mannosan,95%
2025/8/5 13:25:56
LY 278584
2025/8/5 13:25:51
(all-Z)-6,9,12,15,18-Heneicosapentaenoic acid ethyl ester
2025/8/5 13:25:49
N-Methylnicotinamide (Standard)
2025/8/5 13:25:47
Auhagy-IN-4
2025/8/5 13:25:46
Runx1-CBF�� interaction inhibitor 1
2025/8/5 13:25:44
BM567
2025/8/5 13:25:41
L-6355
2025/8/5 13:25:36
C14 Ceramide
2025/8/5 13:25:34
(R)-Levrazoxane
2025/8/5 13:25:32
Isopropyl myristate (Standard)
2025/8/5 13:25:09
���T�x����
Һ��ɫ�V�x
����ɫ�V�x
ԭ�ӟɹ���V�x
��Ҋ�ֹ���Ӌ
Һ�|(zh��)(li��n)�Ãx
����ԇ�C(j��)
���Ӌ��PHӋ��
�x�ęC(j��)
�����x�ęC(j��)
����x�ęC(j��)
�����@�R
�����@�R
��(bi��o)��(zh��n)���|(zh��)
����ԇ��